Cabaletta Bio, Inc. (CABA)
After hours:
| Previous Close | 12.41 |
| Open | 12.51 |
| Bid | 12.58 x 400 |
| Ask | 12.64 x 600 |
| Day's Range | 12.19 - 13.10 |
| 52 Week Range | 9.02 - 26.35 |
| Volume | |
| Avg. Volume | 1,148,137 |
| Market Cap | 607.939M |
| Beta (5Y Monthly) | 2.41 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Cabaletta Bio Inc (CABA) Earnings: Aligns with EPS Projections, Forecasts Extended Cash Runway
Q4 and Full Year 2023 Financial Results Reveal Strategic Advancements in Autoimmune Therapies
- Insider Monkey
Jim Cramer’s 10 Latest Stock Picks This Week
In this article, we will take a detailed look at Jim Cramer’s 10 Latest Stock Picks This Week. For a quick overview of such stocks, read our article Jim Cramer’s 5 Latest Stock Picks This Week. Jim Cramer in his latest program talked about the ever-growing appetite for semiconductor chips in the market, demonstrating the enormous gains of […]
- Insider Monkey
Several Factors Led to the Outperformance of Cabaletta Bio (CABA) in Q4
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The fourth quarter witnessed a significant easing in financial conditions, which was most notable in the final two months. Class A shares of the fund outperformed the Russell […]
